Pediatrix Medical Group, Inc.
NYQ: MD📈 ZcoreAI Score
Our AI model analyzes Pediatrix Medical Group, Inc.'s price action across multiple timeframes using regression channels and statistical scoring.
Get MD Z-Score →About Pediatrix Medical Group, Inc.
📊 Fundamental Analysis
Pediatrix Medical Group, Inc. demonstrates a profit margin of 8.6%, which is below the sector average, suggesting competitive pressure.
The company recently reported -1.7% revenue growth, which is negative, indicating a recent decline in revenue.
Return on Equity (ROE) is 20.3%, which exceeds the Healthcare sector average, reflecting efficient capital allocation.
At a current price of $21.45, MD currently sits at the 73rd percentile of its 52-week range (Range: $11.84 - $24.99).
💰 Valuation Insight
MD trades at a 55.8% discount (PE: 11.06), which may represent a value opportunity given the sector average of 25.00. Analysts expect earnings growth, as indicated by a lower forward PE.